Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CRYO CELL INTERNATIONAL INCCCEL · Entity 7400 | Director | October 21, 2025 | October 23, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CRYO CELL INTERNATIONAL INC
Report date October 21, 2025 · Filed October 23, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $4.35 · Expires 2035-10-21 | Direct | 5,300 |
Reported balance
After 2025-10-21 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2025-10-21 · Grant · Acquired 5,300 · Balance 5,300 |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $7.53 · Expires 2029-08-30 | Direct | 7,500 |
Reported balance
Holding disclosure · report date 2025-10-21 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 7,500 |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $7.74 · Expires 2029-11-25 | Direct | 5,300 |
Reported balance
Holding disclosure · report date 2025-10-21 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 5,300 |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $7.85 · Expires 2030-09-22 | Direct | 5,300 |
Reported balance
Holding disclosure · report date 2025-10-21 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 5,300 |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $12.63 · Expires 2031-10-20 | Direct | 5,300 |
Reported balance
Holding disclosure · report date 2025-10-21 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 5,300 |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $6.50 · Expires 2032-10-03 | Direct | 5,300 |
Reported balance
Holding disclosure · report date 2025-10-21 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 5,300 |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $4.90 · Expires 2033-10-10 | Direct | 5,300 |
Reported balance
Holding disclosure · report date 2025-10-21 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 5,300 |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $5.82 · Expires 2034-10-29 | Direct | 5,300 |
Reported balance
Holding disclosure · report date 2025-10-21 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 5,300 |
| Common StockSEC Table I · non-derivative | Direct | 57,901 |
Reported balance
Holding disclosure · report date 2025-10-21 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 57,901 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 21, 2025 Filed Oct 23, 2025 21:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantStock Option · Derivative | 5,300 | $4.35 Strike: $4.35 | $23,055.00 |
DisclosureSEC source: 0001193125-25-248884 · ownership.xml · derivative · entry 9 Berger Harold D. · CIK 0001529398 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,300 Underlying: Common Stock · 5,300 shares Expires 2035-10-21 Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 21:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | Exercise / conversionStock Option · Derivative | 7,500 | $3.08 Strike: $3.08 | $23,100.00 |
DisclosureSEC source: 0000950170-25-095095 · ownership.xml · derivative · entry 10 Berger Harold D. · CIK 0001529398 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2025-07-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 21:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | Exercise / conversionCommon Stock | 7,500 | $3.08 | $23,100.00 |
DisclosureSEC source: 0000950170-25-095095 · ownership.xml · nonDerivative · entry 2 Berger Harold D. · CIK 0001529398 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,901 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 29, 2024 Filed Oct 31, 2024 21:29 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantStock Option · Derivative | 5,300 | $5.82 Strike: $5.82 | $30,846.00 |
DisclosureSEC source: 0000950170-24-119672 · ownership.xml · derivative · entry 8 Berger Harold D. · CIK 0001529398 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,300 Underlying: Common Stock · 5,300 shares Expires 2034-10-29 F1 · derivative.exercise_date: Stock options vest at a rate of 1/12 per month commencing on October 29, 2024. Read SEC document |
| October 10, 2023 Filed Oct 12, 2023 21:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantStock Option · Derivative | 5,300 | $4.90 Strike: $4.90 | $25,970.00 |
DisclosureSEC source: 0001209191-23-052706 · doc4.xml · derivative · entry 8 Berger Harold D. · CIK 0001529398 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,300 Underlying: Common Stock · 5,300 shares Expires 2033-10-10 F1 · derivative.exercise_date: Stock options vest at a rate of 1/12 per month commencing on October 10, 2023. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 21:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantStock Option · Derivative | 5,300 | $6.50 Strike: $6.50 | $34,450.00 |
DisclosureSEC source: 0001209191-22-052800 · doc4.xml · derivative · entry 7 Berger Harold D. · CIK 0001529398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,300 Underlying: Common Stock · 5,300 shares Expires 2032-10-03 F2 · derivative.exercise_date: Stock options vest at a rate of 1/12 per month commencing on October 3, 2022. Read SEC document |
| August 31, 2022 Filed Sep 1, 2022 21:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | Exercise / conversionStock Option · Derivative | 7,500 | $2.40 Strike: $2.40 | $18,000.00 |
DisclosureSEC source: 0001209191-22-048264 · doc4.xml · derivative · entry 6 Berger Harold D. · CIK 0001529398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2024-07-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 31, 2022 Filed Sep 1, 2022 21:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | Exercise / conversionStock Option · Derivative | 7,500 | $1.95 Strike: $1.95 | $14,625.00 |
DisclosureSEC source: 0001209191-22-048264 · doc4.xml · derivative · entry 5 Berger Harold D. · CIK 0001529398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2023-07-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 31, 2022 Filed Sep 1, 2022 21:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | Exercise / conversionCommon Stock | 7,500 | $2.40 | $18,000.00 |
DisclosureSEC source: 0001209191-22-048264 · doc4.xml · nonDerivative · entry 3 Berger Harold D. · CIK 0001529398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,401 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 31, 2022 Filed Sep 1, 2022 21:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | Exercise / conversionCommon Stock | 7,500 | $1.95 | $14,625.00 |
DisclosureSEC source: 0001209191-22-048264 · doc4.xml · nonDerivative · entry 2 Berger Harold D. · CIK 0001529398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,901 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 07, 2022 Filed Sep 1, 2022 21:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | Exercise / conversionStock Option · Derivative | 7,500 | $2.04 Strike: $2.04 | $15,300.00 |
DisclosureSEC source: 0001209191-22-048264 · doc4.xml · derivative · entry 4 Berger Harold D. · CIK 0001529398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2022-07-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 07, 2022 Filed Sep 1, 2022 21:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | Exercise / conversionCommon Stock | 7,500 | $2.04 | $15,300.00 |
DisclosureSEC source: 0001209191-22-048264 · doc4.xml · nonDerivative · entry 1 Berger Harold D. · CIK 0001529398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,401 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 20, 2021 Filed Oct 21, 2021 21:01 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantStock Option · Derivative | 5,300 | $12.63 Strike: $12.63 | $66,939.00 |
DisclosureSEC source: 0001209191-21-061275 · doc4.xml · derivative · entry 9 Berger Harold D. · CIK 0001529398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,300 Underlying: Common Stock · 5,300 shares Expires 2031-10-20 F2 · derivative.exercise_date: Stock options vest at a rate of 1/12 per month commencing on October 20, 2021. Read SEC document |
| September 22, 2020 Filed Sep 24, 2020 19:55 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantStock Option · Derivative | 5,300 | $7.85 Strike: $7.85 | $41,605.00 |
DisclosureSEC source: 0001209191-20-051871 · doc4.xml · derivative · entry 8 Berger Harold D. · CIK 0001529398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,300 Underlying: Common Stock · 5,300 shares Expires 2030-09-22 F7 · derivative.exercise_date: Stock options vest at a rate of 1/12 per month commencing on September 22, 2020 Read SEC document |
| July 14, 2020 Filed Jul 15, 2020 21:29 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon stock | 700 | $7.65 | $5,355.00 |
DisclosureSEC source: 0000899243-20-019190 · doc4.xml · nonDerivative · entry 2 Berger Harold D. · CIK 0001529398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,801 Read SEC document |
| July 13, 2020 Filed Jul 15, 2020 21:29 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon Stock | 971 | $7.63 | $7,408.73 |
DisclosureSEC source: 0000899243-20-019190 · doc4.xml · nonDerivative · entry 1 Berger Harold D. · CIK 0001529398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,101 Read SEC document |
| November 25, 2019 Filed Dec 12, 2019 22:32 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantStock Option · Derivative | 5,300 | $7.74 Strike: $7.74 | $41,022.00 |
DisclosureSEC source: 0000899243-19-029062 · doc4.xml · derivative · entry 9 Berger Harold D. · CIK 0001529398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,300 Underlying: Common Stock · 5,300 shares Expires 2026-11-25 F7 · derivative.exercise_date: Stock options vest at a rate of 1/12 per month commencing on November 25, 2019. Read SEC document |
| November 25, 2019 Filed Jul 15, 2020 21:29 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantStock Option · Derivative | 5,300 | $7.74 Strike: $7.74 | $41,022.00 |
DisclosureSEC source: 0000899243-20-019190 · doc4.xml · derivative · entry 8 Berger Harold D. · CIK 0001529398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,300 Underlying: Common Stock · 5,300 shares Expires 2026-11-25 F6 · derivative.exercise_date: Stock options vest at a rate of 1/12 per month commencing on November 25, 2019. Read SEC document |
| November 21, 2019 Filed Dec 12, 2019 22:32 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | OtherStock Option · Derivative | 7,500 | $7.00 Strike: $7.00 | $52,500.00 |
DisclosureSEC source: 0000899243-19-029062 · doc4.xml · derivative · entry 8 Berger Harold D. · CIK 0001529398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2027-07-18 F6 · kind: Stock options surrendered as a result of the ratification of stock issuances and equity awards at the Company's Annual Meeting of Shareholders on November 21, 2019. Read SEC document |
| November 21, 2019 Filed Dec 12, 2019 22:32 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | OtherStock Option · Derivative | 7,500 | $3.50 Strike: $3.50 | $26,250.00 |
DisclosureSEC source: 0000899243-19-029062 · doc4.xml · derivative · entry 7 Berger Harold D. · CIK 0001529398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2026-07-06 F6 · kind: Stock options surrendered as a result of the ratification of stock issuances and equity awards at the Company's Annual Meeting of Shareholders on November 21, 2019. Read SEC document |
| August 30, 2019 Filed Sep 4, 2019 21:15 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantStock Option · Derivative | 7,500 | $7.53 Strike: $7.53 | $56,475.00 |
DisclosureSEC source: 0000899243-19-022747 · doc4.xml · derivative · entry 8 Berger Harold D. · CIK 0001529398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2029-08-30 F7 · derivative.exercise_date: Stock options vest at a rate of 1/12 per month commencing on August 30, 2019. Read SEC document |
| August 29, 2018 Filed Aug 29, 2018 21:12 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | Exercise / conversionStock Options · Derivative | 20,000 | $2.70 Strike: $2.70 | $54,000.00 |
DisclosureSEC source: 0000899243-18-023487 · doc4.xml · derivative · entry 2 Berger Harold D. · CIK 0001529398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2018-08-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Stock options vest at a rate of 1/3 per year commencing on August 30, 2011. Read SEC document |
| August 29, 2018 Filed Aug 29, 2018 21:12 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | Exercise / conversionCommon Stock | 20,000 | $2.70 | $54,000.00 |
DisclosureSEC source: 0000899243-18-023487 · doc4.xml · nonDerivative · entry 1 Berger Harold D. · CIK 0001529398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,130 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 18, 2017 Filed Aug 29, 2017 21:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantStock Option · Derivative | 7,500 | $7.00 Strike: $7.00 | $52,500.00 |
DisclosureSEC source: 0000899243-17-021181 · doc4.xml · derivative · entry 8 Berger Harold D. · CIK 0001529398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2027-07-18 F7 · derivative.exercise_date: Stock options vest at a rate of 1/12 per month commencing on July 18, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.